Goldman Sachs Group Inc
Change company Symbol lookup
Select an option...
GS Goldman Sachs Group Inc
ONON On Holding AG
XNCR Xencor Inc
ALT Altimmune Inc
RZLT Rezolute Inc
BNKU MicroSectors? U.S. Big Banks Index 3X Leveraged ETNs
SGFY Signify Health Inc
FRC First Republic Bank
BACK IMAC Holdings Inc
LYLT Loyalty Ventures Inc
Go

Financials : Capital Markets | Large Cap Value
Company profile

The Goldman Sachs Group, Inc. is a global financial institution that delivers a range of financial services across investment banking, securities, investment management and consumer banking to a diversified client base that includes corporations, financial institutions, governments and individuals. The Company segments include Global Banking & Markets, Asset & Wealth Management and Platform Solutions. The Global Banking & Markets segment includes financing, advisory services, risk distribution, and hedging for its institutional and corporate clients, including Fixed Income, Currency and Commodities (FICC) and Equities, Investment Banking and Marquee. The Asset & Wealth Management segment includes advice, investing, and execution for institutions and individuals across public and private markets. The Platform Solutions segment includes consumer platforms, such as partnerships offering credit cards and point-of-sale financing, and transaction banking and other platform businesses.

Price
Delayed
$317.29
Day's Change
7.76 (2.51%)
Bid
--
Ask
--
B/A Size
--
Day's High
320.32
Day's Low
315.35
Volume
(Light)

Today's volume of 1,610,507 shares is on pace to be much lighter than GS's 10-day average volume of 4,214,926 shares.

1,610,507

AbbVie Inc. Stock Underperforms Thursday When Compared To Competitors

4:33 pm ET January 19, 2023 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of AbbVie Inc. (ABBV) slipped 0.33% to $148.71 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.76% to 3,898.85 and Dow Jones Industrial Average falling 0.76% to 33,044.56. This was the stock's third consecutive day of losses. AbbVie Inc. closed $27.20 short of its 52-week high ($175.91), which the company reached on April 8th.

The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) fell 0.14% to $169.53 and Pfizer Inc. (PFE) fell 0.09% to $44.96. Trading volume (7.2 M) eclipsed its 50-day average volume of 5.4 M.

Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 19, 2023.

	

(END) Dow Jones Newswires

January 19, 2023 16:33 ET (21:33 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.